S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10

Zomedica Stock Forecast, Price & News

0.00 (0.00%)
(As of 01/27/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
10.59 million shs
Average Volume
11.38 million shs
Market Capitalization
$274.37 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive ZOM News and Ratings via Email

Sign-up to receive the latest news and ratings for Zomedica and its competitors with MarketBeat's FREE daily newsletter.

Zomedica logo

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA, a diagnostic biosensor platform for the detection of thyroid disorders in dogs and cats, and adrenal disorders in dogs. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.


See More Headlines

Industry, Sector and Symbol

Stock Exchange
Pharmaceutical preparations
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
Book Value
$0.09 per share


Net Income
$-16.91 million
Pretax Margin




Free Float
Market Cap
$274.37 million
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

1.27 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Zomedica (NYSEAMERICAN:ZOM) Frequently Asked Questions

How has Zomedica's stock price been impacted by COVID-19 (Coronavirus)?

Zomedica's stock was trading at $0.2078 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ZOM shares have increased by 34.7% and is now trading at $0.28.
View which stocks have been most impacted by COVID-19

When is Zomedica's next earnings date?

Zomedica is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Zomedica

How were Zomedica's earnings last quarter?

Zomedica Corp. (NYSEAMERICAN:ZOM) announced its quarterly earnings data on Friday, November, 12th. The company reported ($0.01) earnings per share for the quarter. The firm earned $0.02 million during the quarter.
View Zomedica's earnings history

Who are Zomedica's key executives?

Zomedica's management team includes the following people:
  • Mr. Robert Cohen, CEO & Director (Age 63, Pay $412.79k)
  • Ms. Ann Marie Cotter CPA, CFO & Sec. (Age 50)
  • Dr. Stephanie Laine Morley D.V.M., DVM, Consultant (Age 46, Pay $282.7k)
  • Mr. Bruk Herbst, Chief Commercial Officer (Age 52, Pay $208.97k)
  • Mr. Michael Schilk, VP of Sales
  • Mr. David Eaton, VP of Marketing
  • Dr. William Carpenter MacArthur, Consultant (Age 58)
  • Mr. Robert W. DiMarzo, Consultant (Age 64)

What is Zomedica's stock symbol?

Zomedica trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ZOM."

How do I buy shares of Zomedica?

Shares of ZOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zomedica's stock price today?

One share of ZOM stock can currently be purchased for approximately $0.28.

How much money does Zomedica make?

Zomedica has a market capitalization of $274.37 million. The company earns $-16.91 million in net income (profit) each year or ($0.06) on an earnings per share basis.

How many employees does Zomedica have?

Zomedica employs 19 workers across the globe.

What is Zomedica's official website?

The official website for Zomedica is www.zomedica.com.

Where are Zomedica's headquarters?

Zomedica is headquartered at 100 PHOENIX DRIVE SUITE 125, ANN ARBOR MI, 48108.

How can I contact Zomedica?

Zomedica's mailing address is 100 PHOENIX DRIVE SUITE 125, ANN ARBOR MI, 48108. The company can be reached via phone at 734-369-2555 or via email at [email protected].

This page was last updated on 1/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.